Goodsurance

Policy & oversight

New 2027 pay rules for dialysis care

Medicare proposed its 2027 payment update for dialysis clinics, a roughly 1 percent raise that also folds a common kidney drug into the standard payment. For the half million Americans on dialysis, this is the plumbing behind the chair.

By the Goodsurance editorial teamJune 29, 2026

Most Medicare news is about premiums and plans. This one is about the machinery that keeps a specific kind of care running. On June 26, 2026, Medicare proposed its payment rules for dialysis clinics for 2027. Medicare pays for almost everyone with end stage kidney disease, regardless of age, so these rules touch roughly half a million Americans who rely on dialysis to stay alive. The proposal would raise the base payment for a dialysis treatment from $281.71 to $299.55, an increase of about 1.1 percent across the roughly 7,600 clinics that provide this care, with Medicare expecting to pay about $6.2 billion in total. Part of that increase reflects a quieter change that matters to patients: oral phosphate binders, common drugs that people on dialysis take to control phosphorus levels, would be folded into the single bundled dialysis payment rather than billed separately. In plain terms, the clinic is paid one rate that is meant to cover the treatment and more of the related drugs together. None of this is something a patient signs up for or opts out of; it is the funding formula behind the care. Why pay attention at all? Because how clinics are paid shapes where they can operate and how steady that care is, especially in rural areas where a single clinic may be the only option for miles. The rule is a proposal open for public comment through August 24, 2026, not a final decision. The pointed framing about whether a 1 percent update keeps pace with real costs, and what it means for clinic consolidation, routes to my65checklist; here the job is simply to explain what changed and who it touches.

In plain words

Most Medicare news is about premiums and plans. This story is different. It is about how Medicare pays the clinics that give dialysis. Dialysis keeps people with failing kidneys alive. Medicare covers almost everyone who needs it, at any age. About half a million Americans count on it. On June 26, 2026, Medicare proposed how it will pay dialysis clinics in 2027. The base payment for one treatment would go up from $281.71 to $299.55, about 1 percent more. There are about 7,600 clinics, and Medicare expects to pay around $6.2 billion in all. One change matters to patients: a common kidney drug, called a phosphate binder, would be paid for as part of the dialysis payment instead of on its own. You do not sign up for any of this. It is the money behind the care. It matters because how clinics get paid affects where they can stay open, especially in country areas. This is just a proposal for now. People can comment until August 24, 2026.

Source: Centers for Medicare and Medicaid Services
Read at the source →

More news

Other stories on what is moving in Medicare.

Policy & oversight

OIG Found More Than 15 Million Dollars in Medicare Payments Where Emergency Room Billing Codes Were Used at Non-Emergency Sites

A March 2026 federal audit identified improper and potentially improper Medicare payments made when physicians and hospitals used emergency department billing codes for care not actually delivered in an emergency department, and found that Medicare lacked automated safeguards to catch the mismatches.

August 8, 2026

Policy & oversight

Federal Audit Found at Least 4.7 Million Dollars in Medicare Overpayments at an Arkansas Hospital

An OIG audit of Jefferson Regional Medical Center found a high rate of billing errors on claims flagged as elevated risk, producing an estimated 4.7 million dollars in improper Medicare payments. The hospital disputed most of the findings.

August 7, 2026

Policy & oversight

CMS Publishes Plan to Speed Medicare Coverage for Breakthrough Medical Devices

A new pathway would give FDA-cleared breakthrough devices a national Medicare coverage decision within weeks of regulatory approval, rather than waiting years under the standard process.

August 7, 2026

Policy & oversight

Federal Audit Found 97 Cybersecurity Gaps in Medicare Billing Contractors for Fiscal Year 2024, Though the Most Serious Deficiencies Declined

An OIG annual report to Congress found information security deficiencies across all seven Medicare administrative contractors in fiscal year 2024, while noting that high-risk and moderate-risk gaps fell compared with the prior year.

August 6, 2026

Policy & oversight

CMS Published Second-Quarter 2026 Drug Coding Decisions That Shape How Medicare Identifies and Pays for New Medicines

The quarterly HCPCS drug coding update, posted July 29 and highlighted in the August 6 MLN Connects newsletter, determines which new medications and biologicals get a dedicated Medicare billing code.

August 6, 2026

Policy & oversight

CMS Sets a Sunset Date for the NTAP Alternative Track for Breakthrough Devices and Advances the RAPID Pathway

The fiscal year 2027 hospital payment final rule phases out the alternative NTAP track that breakthrough-designated devices used to qualify for Medicare reimbursement, while a new CMS-FDA program called RAPID is positioned to take its place.

August 5, 2026